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ABSTRACT: Hepatitis B virus (HBV) infection is one of the major public health problems globally. This 
study aims to determine the frequency of occurrence of HBV infection and associated risk factors for 
acquisition of the disease in clinically-ill adult patients attending selected government hospitals in Ondo State, 
Nigeria. Seven hundred and sixty-seven (767) ill adult individuals attending five medical out-patient 
Departments of the hospitals who consented to the study were recruited for the investigation. A structured 
questionnaire which covered sociodemographic characteristics and risk factors were used for primary 
information. Positivity for HBV was determined using a quality assured commercial enzyme linked 
immunosorbent assay (ELISA) kit for the detection of Hepatitis B surface antigen (HBsAg). Of the 767 
patients, 11.0% were positive for HBsAg. The prevalence rate for HBsAg positivity was higher in the males 
(13.5%) than the females (9.3%) (pv = 0.043). The study also revealed the highest prevalence rate of HBsAg 
infection among the age group 19 – 39 years with mean percentage of 17.5%. Alcohol consumption, history of 
HBV in the family, multiple sex partners, history of injections in road side chemist shops, and intake of 
traditional herbs showed significant association respectively (p < 0.05), however no significant association 
among individuals with history of HBV vaccination, blood transfusion and tattoo/tribal mark (p > 0.05). 
Conclusively, this study gives information on the prevalence rate of HBV in the community sampled to be 
11.0%. This shows that HBV is endemic in Ondo State, Southwest Nigeria. 
Keywords: Hepatitis B Virus; Hepatitis B surface antigen; Risk factors; Sero-prevalence; Socio-demographic 
data. 
1. INTRODUCTION 
Hepatitis B is a disease cause by Hepatitis B Virus (HBV) and it belongs to the genus 
Orthohepadnavirus in the family Hepadnaviridae. It contains deoxyribonucleic acid (DNA) as its major 
genetic material composed of a 27 nm nucleocapsid core which is coated by a surface antigen called the 
Hepatitis B surface Antigen (HBsAg) [1, 2]. As at 2015, preceding records showed that more than 2 billion 
people have been infected with HBV with almost 257 million people chronically infected with HBV [3, 4]. 
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Annual estimate indicates that about 4.5 million new cases occurred, and about 887,000 people die globally 
from chronic HBV infection with major cause of mortality being liver cancer (38%) and cirrhosis (52%) [6, 
7]. Globally, Africa records the second largest cases of chronic HBV carriers after Asia and therefore 
represents a region of high endemicity [8]. Seventy percent of chronic HBV infection is estimated to occur in 
low-income countries and the prevalence is highest in the sub-Saharan African countries including Nigeria 
with prevalence rate of 10-26% among the general population [7, 9-12].  
The major routes of HBV transmission have been reported to include; sexual contact, infected blood 
transfusion, and usage of unsterilized equipment for medical procedures and sharing of sharp materials [13, 
14]. Although, perinatal exposure to HBV constitutes the most predisposing mode of transmission among 
individuals in areas of medium to high endemicity [15]. Infected mothers who are positive for HBsAg and 
HBeAg markers have ≥90% chance of transmitting the virus to their babies. Such babies have higher chance 
of becoming chronic carriers later in life [16]. Fifteen to 25% of these children have risk of dying from 
cirrhosis or liver cancer during adulthood [17, 18]. 
Most studies carried out in Nigeria on the HBV seroprevalence and risk factors are among pregnant 
women which are also at regional bases hence this study is aimed to determine the frequency of occurrence of 
HBV infection and associated risk factors for acquisition of the disease in clinically ill adult patients attending 
selected government health facilities in Ondo State, Nigeria. 
2. MATERIALS AND METHODS 
2.1. The study population 
Blood samples were collected from sick individuals who sought medical attention at 5 selected 
government hospitals in Ondo State, Nigeria. The selected health facilities were; Government State Hospital, 
Ikare, Federal Medical Center, Owo, University of Medical Sciences Teaching hospital (UNIMED) Annex, 
Akure, UNIMED Teaching Hospital Complex Ondo and Government State Hospital, Okitipupa.  
2.2. Structured questionnaires  
A total of 767 structured questionnaires which covers the demographic information and risk factors for 
HBV infection were administered to the participants that consented to participate in the study. The 
questionnaire covered age, sex, marital status, educational status, occupational status, history of blood 
transfusion, history of sexual partners   alcohol consumption, history of injection at the road side chemist 
shop, history of liver disease in the family, history of pains on the right side of the stomach and HBV 
vaccination. The questionnaire did not include their identification particulars, thus safeguarding anonymity. 
Following the filling of the questionnaire and written consent form, they were then recruited for the study. 
2.3. Blood sample collection 
The collection of blood was done at the Medical Out Patient Department (MOPD) of all the hospitals. 
Five milliliter (5 ml) of blood sample was collected from each participant from their antecubital vein using a 
labelled plain vacutainer container (BD Vacutainer, Plymouth, PL6 7P. UK) after filling the questionnaire. The 
blood samples were transported to the laboratory in a cold chain after which they were retracted and 
centrifuged at 500 x g for 5 minutes using centrifuge 80-3 (Labscience, England). The serum was harvested 
into 2 ml cryovials and stored at -20oC until analyzed.   
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2.4. ELISA serological assay for HBsAg and HBV markers 
The stored blood serum samples were brought out from the freezer where they were stored and allowed 
to thaw and attain room temperature before the assay. They were analyzed using third generation 
commercially-available sandwich enzyme linked immunosorbent assay (ELISA) kits for detection of HBsAg. 
The blood samples that were positive for HBsAg samples were further assayed for HBeAg, HBsAb and 
HBcAb (DIA.PRO Diagnostic Biopobes Sri Via G. Carducci no 27 20099 Sesto San Giovanni (Milano) – 
Italy). The assayed samples were read at 450 nm filter via ELISA machine; Dynatec MR. 5000 ELISA reader.  
2.5. Statistical analysis 
Statistical analyses were performed using SSPS (version 16.0). The prevalence of HBV markers of the 
studied population was calculated at 95% confidence intervals (CI). The demographic and risk factors 
variables and prevalence of hepatitis B markers were evaluated using Chi-square.  
3. RESULTS 
Out of a total of 767 adult patients that were recruited for the study, 11.0% (84/767) were positive for 
HBsAg (Figure 1). Based on gender, 13.5% (41/303) of the male participants and 9.3% (43/464) of the 
females recruited were positive for HBsAg (Table 1, p = 0.043.) The age group of 19-29 years had the highest 
percentage positivity with 17.9% which was followed by the age range of 30-39 years with 17.0%, age range 
50-59 years with 12.6% and the least was age range of 80 years and above with 0% (Table 1). Furthermore, 
the study showed that singles had the highest positivity with 19.1% (22/115) which showed a significant 
association (p = 0.003) while the married with 9.5% (62/652) positivity (Table 1). Significant association was 
found (p = 0.042) in the educational status with 15.3% (13/83) in those that did not have any form of 
education. This was followed by those with tertiary education with 12.0% (42/351) and then secondary 
education with 11.8% (21/178) (Table 1). Moreover, from the study, unemployed adults had the highest 
positivity for HBsAg with 13.6%  (42/309) which was followed by retirees with 12.9% (8/62), house wives 
with 11.4% (5/44) and the self-employed (Farming, trading, tailoring and business) with 10.1% (21/207) and 
the least was observed in civil servants with 5.5% (8/145) (Table 1). 
 
 
Figure 1. Seroprevalence of HBsAg among patients attending selected Health Institutions in Ondo State. 
 
Table 2 showed that of the 84 patients positive for HBsAg, 37 (44%) were positive for HBeAg while 
47 (56%) were negative. Also, 15 (17.9%) were positive for HBsAb while 69 (82.1%) were negative. 
Furthermore, 18 (21.4%) were positive for HBcAb while 66 (78.6%) were negative respectively.  
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Table 1. Assessment of risk factors of HBV Seropositivity among patients attending Selected Health Institutions in Ondo 
State. 
Variables Frequency Percentage (%) % HBsAg positivity p-values 
Gender     
Male 303 39.5 41 (13.5) 
pv = 0.043 
Female 464 65.5 43 (9.3) 
Age Range (years)     
18 - 29 106 13.8 19 (17.9)  
30 - 39 100 13.0 17 (17.0)  
40 - 49 127 16.6 15 (11.8)  
50 - 59 167 21.8 21 (12.6)  
60 - 69 140 18.3 6 (4.3)  
70 - 79 103 13.4 6 (5.8)  
≥ 80 24 3.1 0 (0)  
Marital Status     
 
Married 652 85.0 62 (9.5) 
pv = 0.003 
Single 115 15.0 22 (19.1) 
Educational Status     
Primary 153 19.9 8 (5.1) 
pv = 0.042 
Secondary 178 23.2 21 (11.8) 
Tertiary 351 45.8 42 (12.0) 
None 85 11.1 13 (15.3) 
Occupation     
Self employed (Farming, Trading, 
Tailoring and Business) 
207 49.7 21 (10.1)  
Unemployed 309 6.8 42 (13.6)  
Retiree 62 15.3 8 (12.9)  
House wife 44 3.3 5 (11.4)  
History of blood transfusion     
Yes 75 9.8 12 (16.0) 
pv = 0.170 
No 692 90.2 72 (10.4) 
Tribal marks/tattoo     
Yes 166 21.6 22 (13.3) 
pv = 0.325 
No 601 78.4 62 (10.3) 
Experience pain on the right side of the stomach    
Yes 73 8.4 27 (37.0) 
pv = 0.0001 
No 694 91.6 57 (8.2) 
Alcohol consumption     
Yes 123 16.0 29 (23.6) 
pv = 0.001 
No 644 84.0 55 (8.5) 
No of sexual partners     
1 645 84.1 68 (10.5)  
2 55 7.2 7 (12.7)  
3 12 1.6 3 (25.0)  
4 55 7.2 6 (10.9)  
History of liver disease in the family    
Yes 26 3.2 12 (46.2) pv = 0.0001 
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Variables Frequency Percentage (%) % HBsAg positivity p-values 
No 741 96.8 72 (9.7) 
History of HBV vaccination     
Yes 98 12.8 18 (18.4) 
pv = 0.057 
No 669 87.2 66 (9.9) 
History of injection on roadside chemist shop    
Yes 98 12.8 18 (18.4) 
pv = 0.057 
No 669 87.2 66 (9.9) 
History of traditional herb usage     
Yes 426 55.5 61 (14.3) 
pv = 0.016 
No 341 45.5 23 (6.7) 
 
Table 2. Distribution of HBV markers among HBsAg positive patients in Ondo State tested (n = 84). 
HBV Markers Positive (%) Negative (%) 
HBeAg 37 (44.0) 47 (56.0) 
HBsAb 15 (17.9) 69 (82.1) 
HBcAb 18 (21.4) 66 (78.6) 




Figure 2. Age and gender distribution of Hepatitis B virus positive patients attending selected government hospitals in 
Ondo State. 
 
Figure 2 shows, the highest percentage in the male participants were in the age range of 19-29 years 
with 21.7% (13/60) while age range of 30-39 years with 17.9% (12/67) in the female participants. This was 
followed by age range 30-39 years in the males with 18.2% (6/33) while age range of 50-59 years with 13.2% 
(16/121) in the females. Only the male participants within the age range of 70-79 years had positive HBsAg 
with 11.8% (6/51) while in the females it was 0%. 
The study showed insignificant association among patients who had blood transfusion with 16.0% 
(12/75) and patients who had tribal marks/tattoos with 13.3% (22/166) (PV = < 0.05 respectively). However, 
the study further showed a highly significant association among patients who had right-sided stomach pains 
during the period of the study with 37.0% (27/73) (P = 0.0001).                                
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A highly significant association was demonstrated (P = 0.0001) among those that consume alcohol 
with 23.6% (29/123). Furthermore, those with 3 sexual partners had significant association (P = 0.042) with 
25.0% (3/12) while those that had history of liver disease in the family showed a highly Significant 
association (P = 0.0001) with 46.2% (12/26).  
The study also showed that there was no significant association with those who had history of 
vaccination and history of injection in a chemist shop as risk factor for hepatitis positivity (P = 0.179) with 
25.0%, (2/8) (P = 0.230) with 21.1% (4/19) and P > 0.057 with 18.4% (18/98). Table 1 also showed a 
significant association among patients who had history of traditional herbs usage with 14.3% (6 1/426) (PV = 
0. 016). 
 Table 2 showed that of the 84 HbsAg positive patients, 44.0% were also positive for HBeAg while 
56.0% were negative. Also, 17.9 % were positive for HBsAb and 82.1% were negative. Furthermore, 21.4% 
were positive for HBcAb while 78.6% were negative. There was a significant association (PV = 0.040).  
4. DISCUSSION 
Hepatitis B virus (HBV) infection represents one of the major causes of global morbidity and mortality 
[19, 20]. The rate of Hepatitis B carriers varies widely from 0.01% to 20% all around the world [21]. 
Although safe and effective vaccines are available, HBV remains a substantial and devastating health problem 
with new cases still being reported throughout the world [22]. Given the capability of HBV elimination, one 
of the major health priorities is to find the routes of the transmission in order to access the risk factors 
responsible for its spread and to identify the target population of this great emphasis [23]. Finding the 
important transmission routes of hepatitis for the effective prevention of this disease in every country, most 
especially in endemic regions such as Nigeria is therefore necessary. 
In this study, a cumulative HBsAg seroprevalence rate of 11.0% was observed among the adult 
individuals tested portraying the endemicity of hepatitis B in Ondo State, Southwest, Nigeria. This value falls 
within the prevalence values in different regions in Nigeria and in sub-Saharan Africa [24]. This further 
provides more and current information on the tenacity of Hepatitis B virus infection burden in southwest, 
Nigeria. The finding of this study is consistent with the report of a National survey carried out by Olayinka  et 
al. [25] on the seroprevalence of HBV in Nigeria which is also in agreement with the prevalence in some 
Africa countries such as Ghana (5-10%), Cameroon (8-20%), Benin (12%) and Chad (12 %) [26‑28]. 
More females (60.5%) were engaged  than males (39.5%) during the sample collection, but the 
prevalence rate for HBsAg positivity was higher in the males (13.5%) than the females (9.3%) which has 
significant association (pv = 0.043). This is consistent with the National survey carried out in Nigeria on HBV 
which demonstrated males with higher prevalence to HBV infection [25]. This could be attributed to some 
social vices which males are engrossed with, for example indiscriminate alcohol consumption and cult related 
activities. Moreover, the male gender mostly participates in blood transfusion exercises while females are 
generally occupied with house hold activities based on their social, cultural and religious preferences. This 
finding is also in agreement with the studies carried out in Uganda and some other sub-Saharan African 
countries, where chronic HBV infections were reported to be more in males [29-31]. It has also been reported 
in studies carried out in Greece and Taiwan that males are more prone to HBV infection [32, 33]. However, 
studies carried out in Croatian adult population and Cambodia reported that gender has no association with 
HBV seropositivity [31, 34]. 
This study also revealed the higher prevalent rate of HBsAg infection among the youthful age group 
which falls within the age range of 19-39 years with mean percentage of 17.5%. This could be attributed to 
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the fact that people in this age bracket are sexually active so the high risk of contracting HBV infection. They 
also get involved in drug abuse and tattooing. This is in agreement with the report of Koulentaki et al. [35], 
Khokhar et al. [36], Islam et al. [37], and Adoga et al. [38].  The findings of this study are also in agreement 
with a study carried out in Brazil and the Central-West Region [39]. This study however revealed that some of 
the known risk factors associated with HBV infections, for example, history of blood transfusion, tribal 
marks/tattooing and history of HBV vaccination were not having significant association for HBsAg positivity 
among adult individuals recruited. This finding is not the same with earlier findings on the risk factors on 
HBV carried out in Nigeria [40, 41].  
In this study, it was observed that individuals without any form of education were mostly positive for 
HBsAg with 15.3% which has significant association (P < 0.05). This could be attributed to their un-
awareness of the preventive measures of HBV infection indicating the impact of education on HBV infection. 
The findings of this study corroborate with earlier studies in Nigeria on this [42, 43] but disagree with the 
findings of Okonko and Udeze [44] and Agarry and Lekwot [45]. 
This study indicates that alcohol consumption, history of HBV in the family, number of sexual 
partners, history of having injections in the chemist shop, history of taking of local traditional herbs 
concoctions or decoctions called “Agbo” by the Yorubas were all having significant association as risk factors 
for HBsAg infection respectively.   
Regarding family size and family history of HBV, HBV is more frequently transmitted in the families 
with hepatitis B patients [46, 47]. This study also corroborates studies carried out in Australia and China 
which shows the history of HBV in the family to predispose people to the infection than those without such 
history in their family. The findings in this study however showed no significant association among 
individuals with history of HBV vaccination, history of blood transfusion and tattoo/tribal mark as risk factor 
for HBsAg positivity. This disagrees with some existing findings where they reported a significant association 
[48-51].  
This study revealed multiple antigenic markers on HBV studied, for instance, out of the 84 positive 
patients for HbsAg, 44.0% were positive for HBeAg. This is an indication of active replication of HBV 
infection. Its association with other HBV markers is also an indication of chronic hepatitis B virus infection. 
This study also revealed 17.9% positivity for HBsAb which is a suggestion of protective immunity against 
HBV infection [52, 53]. However, 21.4% of the patients positive for HBsAg were positive for HBcAb. This 
suggest the presence of the genetic component of the HBV in the positive HBcAb which makes them very 
infective [54, 55].  
5. CONCLUSION 
The findings of this study suggest that Ondo State, Southwest Nigeria is endemic for HBV infection. 
The outcome of this research is useful for health officers and planners towards coming up with preventing 
strategies of hepatitis B infection among adults as well as providing a robust scientific basis towards control 
of hepatitis B infection. It is recommended that education of the population on modification of lifestyle and 
sexual behaviors will go a long way to help reduce the transmission of the virus. Further investigations 
however are required on those that tested positive and unable to produce immune response for treatment in 
order to prevent them from developing chronic liver disease. 
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